Check Capital Management Inc. CA Purchases 2,850 Shares of Cardlytics, Inc. (NASDAQ:CDLX)

Check Capital Management Inc. CA boosted its position in Cardlytics, Inc. (NASDAQ:CDLX) by 14.0% in the 4th quarter, HoldingsChannel reports. The firm owned 23,200 shares of the company’s stock after acquiring an additional 2,850 shares during the period. Check Capital Management Inc. CA’s holdings in Cardlytics were worth $214,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. FMR LLC lifted its position in shares of Cardlytics by 238.4% in the second quarter. FMR LLC now owns 1,428 shares of the company’s stock valued at $32,000 after buying an additional 1,006 shares during the last quarter. Point72 Hong Kong Ltd acquired a new stake in Cardlytics during the 2nd quarter valued at $38,000. Tower Research Capital LLC TRC boosted its position in Cardlytics by 186.5% during the third quarter. Tower Research Capital LLC TRC now owns 2,137 shares of the company’s stock worth $35,000 after purchasing an additional 1,391 shares during the period. Comerica Bank acquired a new position in shares of Cardlytics in the third quarter valued at $40,000. Finally, Hsbc Holdings PLC raised its position in shares of Cardlytics by 41.2% in the first quarter. Hsbc Holdings PLC now owns 5,149 shares of the company’s stock valued at $287,000 after purchasing an additional 1,503 shares during the period. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Price Performance

NASDAQ:CDLX traded up $0.28 during mid-day trading on Friday, reaching $12.22. 825,265 shares of the company’s stock were exchanged, compared to its average volume of 1,565,785. The company has a debt-to-equity ratio of 1.91, a current ratio of 1.31 and a quick ratio of 1.31. Cardlytics, Inc. has a one year low of $4.94 and a one year high of $20.52. The business’s fifty day simple moving average is $10.74 and its two-hundred day simple moving average is $9.70.

Cardlytics (NASDAQ:CDLX) last announced its earnings results on Thursday, March 14th. The company reported ($0.14) EPS for the quarter. The business had revenue of $89.17 million for the quarter. Cardlytics had a negative return on equity of 25.38% and a negative net margin of 43.56%.

Insider Buying and Selling at Cardlytics

In other news, COO Amit Gupta sold 72,658 shares of the company’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $6.10, for a total transaction of $443,213.80. Following the completion of the sale, the chief operating officer now directly owns 102,342 shares in the company, valued at approximately $624,286.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, insider Nicholas Hollmeyer Lynton sold 12,460 shares of Cardlytics stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $13.69, for a total value of $170,577.40. Following the transaction, the insider now directly owns 71,355 shares of the company’s stock, valued at $976,849.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Amit Gupta sold 72,658 shares of the company’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $6.10, for a total value of $443,213.80. Following the sale, the chief operating officer now owns 102,342 shares of the company’s stock, valued at $624,286.20. The disclosure for this sale can be found here. Insiders sold 85,272 shares of company stock valued at $616,010 in the last three months. Corporate insiders own 0.78% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on CDLX. Needham & Company LLC lifted their target price on shares of Cardlytics from $15.00 to $17.00 and gave the stock a “buy” rating in a report on Tuesday, April 9th. Craig Hallum raised Cardlytics from a “hold” rating to a “buy” rating and upped their target price for the company from $10.00 to $18.00 in a research report on Friday, March 15th. Finally, Lake Street Capital lifted their price target on Cardlytics from $13.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, March 15th.

Cardlytics Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.